Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Immunotherapy with monoclonal antibodies (MoAbs) targeting cytotoxic T lymphocyte-associated antigen 4 (CTLA4) and the programmed death-1 receptor (PD-1) and it

Saved in:

Bibliographic Details
Main Authors:	Haanen, John B. A. G. (Author) , Carbonnel, Franck (Author) , Jordan, Karin (Author)
Format:	Article (Journal)
Language:	English
Published:	2017
In:	Annals of oncology Year: 2017, Volume: 28, Pages: iv119-iv142
ISSN:	1569-8041
DOI:	10.1093/annonc/mdx225
Online Access:	Verlag, Volltext: http://dx.doi.org/10.1093/annonc/mdx225
Author Notes:	J.B.A.G. Haanen, F. Carbonnel, C. Robert, K.M. Kerr, S. Peters, J. Larkin, K. Jordan

Description
Summary:	Immunotherapy with monoclonal antibodies (MoAbs) targeting cytotoxic T lymphocyte-associated antigen 4 (CTLA4) and the programmed death-1 receptor (PD-1) and it
Item Description:	Available online 6 January 2020 Gesehen am 23.04.2020
Physical Description:	Online Resource
ISSN:	1569-8041
DOI:	10.1093/annonc/mdx225